Miacalcin Logo
  Novartis Pharma US

 



MIACALCIN Home
Healthcare Professionals
Professional Main Page
Treatment Guidelines
MIACALCIN Nasal Spray
 
What Is MIACALCIN?
Patient Profile
Dosing & Administration
Patient FAQs
Prescribing Information
Patient Challenges
Patient Education
Resources
Prescribing Information


Novartis Medicare Resource Center

Tools
Clinical Information
Dosing & Administration
Dosing Administration The recommended dose of MIACALCIN Nasal Spray in postmenopausal osteoporotic females is 200 IU per day administered intranasally, in alternate nostrils daily. Use of MIACALCIN Nasal Spray is recommended in conjunction with an adequate calcium (at least 1000 mg elemental calcium per day) and vitamin D (400 IU per day) intake.

How Supplied

Available as a metered-dose solution in 3.7-mL fill glass bottles. It is available in a dosage strength of 200 IU per activation (0.09 mL/spray). Screw-on pumps are provided. The pumps, following priming, will deliver 0.09 mL of solution. MIACALCIN Nasal Spray contains 2200 IU/mL calcitonin-salmon and is provided in individual boxes containing 1 glass bottle and 1 screw-on pump (NDC 0078-0311-54).

Assembly and Usage Instructions

Step 1 Remove bottle from the refrigerator and allow it to reach room temperature.

Step 2 Keeping the bottle upright, remove the rubber stopper from the bottle.

Step 3 Holding the pump unit, remove the opaque plastic protective cap from the bottom of the unit.

Note: Do not depress pump when it is not attached to the bottle.


Step 4 Holding the bottle upright, insert the nasal spray pump unit into the bottle.

Turn the pump clockwise and tighten it until it is securely fastened to the bottle.


Step 5 Holding the bottle upright with the index finger on top of 1 of the 2 side arms of the pump, gently remove the clear protective cap from the top of the nozzle.

Step 6 Prime a New Bottle Only Once

Hold the bottle upright with the index fingers on the 2 side arms of the pump and the thumb on the bottom of the bottle.

Press the arms down fully until there is a full spray. The nasal spray is now ready for use. There is no need to prime the bottle again; this will waste the medication.


Step 7 Just One Spray, Once a Day in Alternate Nostrils

Patient should keep head upright and carefully place the nozzle in 1 nostril, tilting the bottle until it is in a straight line with the nasal passage.

Press firmly down on the pump once to spray the medication into the nose.

It is not necessary to inhale.

Back To Top

Important Points

MIACALCIN Nasal Spray is dispensed in a fine mist—even if patients can't feel it, it's being absorbed
No need to inhale during administration
Won't drip down the back of the throat like over-the-counter nasal sprays

Prime the bottle only once—when it is first opened and assembled
When the first fine mist is visible, the bottle is primed
The pump should not be reprimed before each daily use, as this will waste the medication

Each metered-dose spray offers the proper amount of medication—200 IU per spray
At least 30 days' supply is included in each bottle
Extra medication has been included to accommodate the initial priming

Opened bottles in use should be stored upright at room temperature—(not to exceed 77ºF [25ºC])
The protective cap should be on the bottle whenever it is not in use
A bottle should not be stored on its side or in its plastic tray after it has been assembled or it may need to be reprimed

Store unused bottles in the refrigerator—not the freezer

Discard all unrefrigerated bottles after 35 days—whether opened or unopened
Refrigerated bottles are good until the expiration date stamped on the bottle and box

Clean the unit regularly—to help keep it sanitary
Once or twice a week, the nozzle should be wiped with a clean damp cloth, then dried before replacing the dust cap.

For further information, please consult the complete Prescribing Information.

Back To Top


Home | Professional Main Page | Treatment Guidelines
MIACALCIN Nasal Spray | Patient Challenges | Patient Education
Resources | Prescribing Information



Novartis Pharma US Use of website is governed by the Terms of Use and Privacy Statement .
Copyright ©2008
Novartis Pharmaceuticals Corporation. All rights reserved.

Novartis proudly supports the Together Rx Access program.
Together Rx Access